MiMedx Group's stock price rose after a strong earnings report, but concerns arise from a high accrual ratio indicating low free cash flow. The company's increase in new shares could impact future profitability and shareholder value.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing